Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأ...
Saved in:
Published in | Journal of Taibah University Medical Sciences Vol. 14; no. 6; pp. 560 - 565 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Saudi Arabia
Elsevier Ltd
01.12.2019
Taibah University Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1658-3612 1658-3612 |
DOI | 10.1016/j.jtumed.2019.09.005 |
Cover
Loading…
Abstract | لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية.
في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر.
كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١).
أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية.
To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).
We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.
The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.
Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. |
---|---|
AbstractList | لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية.
في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر.
كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١).
أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية.
To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).
We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.
The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.
Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. الملخص: أهداف البحث: لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. طرق البحث: في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر. النتائج: كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١). الاستنتاجات: أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية. Abstract: Objectives: To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). Methods: We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. Results: The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Conclusion: Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. الكلمات المفتاحية: الذئبة الحمامية المجموعية, التهاب اللثة, مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا), الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة, المضاد الضوئي المناعي, Keywords: Anti-dsDNA antibody, ELISA, IFN-γ, Periodontitis, SLE To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). We selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).OBJECTIVESTo analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).We selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.METHODSWe selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.RESULTSThe mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.CONCLUSIONResults of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. |
Author | Handono, Kusworini Nurdiana, Nurdiana Kalim, Handono Gofur, Nanda R.P. |
AuthorAffiliation | b Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia a Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia d Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia c Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia |
AuthorAffiliation_xml | – name: c Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – name: d Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – name: b Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – name: a Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia |
Author_xml | – sequence: 1 givenname: Nanda R.P. surname: Gofur fullname: Gofur, Nanda R.P. email: nanda.gofur@gmail.com organization: Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – sequence: 2 givenname: Nurdiana surname: Nurdiana fullname: Nurdiana, Nurdiana organization: Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – sequence: 3 givenname: Handono surname: Kalim fullname: Kalim, Handono organization: Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia – sequence: 4 givenname: Kusworini surname: Handono fullname: Handono, Kusworini organization: Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31908645$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks9u1DAQxiNUREvpGyCUI5cstpN4Yw5IVflXqQIOcLYm9mTXqyRebGerfRzelNlmi1oOIE0Uy_PN75Nn5nl2MvoRs-wlZwvOuHyzWWzSNKBdCMbVglGw-kl2xmXdFKXk4uTB-TS7iHHDGOOc1UKIZ9lpyRVrZFWfZb--YXDe-jG55GJOATF64yChzW9dWufWRYSIecQdSdM-h9HSl1xh_dT2lEiBrkj-_svlXaL1dla5MWHoMPixWMEwQN4ToyeXMd9CcjimOHvEfUw4OJP303aKOYZ9WuMAyccpvsiedtBHvDj-z7MfHz98v_pc3Hz9dH11eVOYWqhUNE0n5XLJEWujGgFlpYDVdgmmk0o2TDS8a1oLUjCmuGkqIYH0KFVbMW5UeZ5dz1zrYaO3wQ0Q9tqD03cXPqw0hORMj7qsK5SghIGqqmTJCdYQgwHhWq5KYr2bWduppSkZemmA_hH0cWZ0a73yOy1VxaQ8AF4fAcH_nDAmPbhosO9hRD9FLcqSHqBUyUn66qHXH5P7GZPg7SwwwccYsNPGJWq_P1i7XnOmDzulN3reKX3YKc0o2KG4-qv4nv-fsmMDaNy4cxh0NDRvg9YFNIla6v4N-A0ASuul |
CitedBy_id | crossref_primary_10_4103_jioh_jioh_205_20 crossref_primary_10_3389_fimmu_2024_1356714 crossref_primary_10_1111_jre_12936 crossref_primary_10_52711_0974_360X_2022_00151 |
Cites_doi | 10.1101/gad.235184.113 10.1016/j.jpeds.2007.09.019 10.1111/j.2041-1014.2009.00562.x 10.1016/j.archoralbio.2014.09.002 10.1159/000358904 10.1590/1677-3225v14n2a02 10.1111/jcpe.12528 10.1016/j.celrep.2016.12.047 10.1093/rheumatology/kem112 10.1111/jcpe.12936 10.14238/sp16.4.2014.292-8 10.21776/ub.eprodenta.2018.002.01.2 10.1371/journal.pone.0170209 10.1111/j.1600-0757.2012.00446.x |
ContentType | Journal Article |
Copyright | 2019 The Authors 2019 The Authors. 2019 The Authors 2019 |
Copyright_xml | – notice: 2019 The Authors – notice: 2019 The Authors. – notice: 2019 The Authors 2019 |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1016/j.jtumed.2019.09.005 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1658-3612 |
EndPage | 565 |
ExternalDocumentID | oai_doaj_org_article_354e6a92ca444631842801c0a7e6b193 PMC6940663 31908645 10_1016_j_jtumed_2019_09_005 S1658361219301088 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0SF 4.4 457 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADEZE AEXQZ AFTJW AGHFR AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ IXB KQ8 M41 M~E NCXOZ O-L O9- OK1 RIG ROL RPM SSZ W2D AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AKBMS AKRWK AKYEP CITATION NPM 7X8 5PM |
ID | FETCH-LOGICAL-c529t-88f66771ee5c982a349a05d7acf69680281f8bda620091c8426a677e69b401c93 |
IEDL.DBID | IXB |
ISSN | 1658-3612 |
IngestDate | Wed Aug 27 01:26:27 EDT 2025 Thu Aug 21 18:33:37 EDT 2025 Fri Jul 11 00:04:23 EDT 2025 Mon Jul 21 06:03:51 EDT 2025 Tue Jul 01 03:12:33 EDT 2025 Thu Apr 24 22:55:23 EDT 2025 Thu Jul 20 20:17:05 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا) IFN-γ Periodontitis المضاد الضوئي المناعي الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة SLE الذئبة الحمامية المجموعية التهاب اللثة Anti-dsDNA antibody ELISA |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. 2019 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c529t-88f66771ee5c982a349a05d7acf69680281f8bda620091c8426a677e69b401c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1658361219301088 |
PMID | 31908645 |
PQID | 2334269931 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_354e6a92ca444631842801c0a7e6b193 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6940663 proquest_miscellaneous_2334269931 pubmed_primary_31908645 crossref_citationtrail_10_1016_j_jtumed_2019_09_005 crossref_primary_10_1016_j_jtumed_2019_09_005 elsevier_sciencedirect_doi_10_1016_j_jtumed_2019_09_005 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-12-01 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Saudi Arabia |
PublicationPlace_xml | – name: Saudi Arabia |
PublicationTitle | Journal of Taibah University Medical Sciences |
PublicationTitleAlternate | J Taibah Univ Med Sci |
PublicationYear | 2019 |
Publisher | Elsevier Ltd Taibah University Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Taibah University – name: Elsevier |
References | Isenberg, Manson, Ehrenstein (bib16) 2007; 46 Isaza-Guzmán, Cardona-Vélez, Gaviria-Correa (bib19) 2015; 60 Mizraji (bib20) 2017; 18 Nazir (bib1) 2017; 1 Rutter-Locher, Fuggle, Orlandi (bib4) 2017; 6 Hajishengallis (bib6) 2010; 25 Hajishengallis (bib12) 2014; 56 Fulop, Witkowsk, Pawelec, Alan, Larbi (bib7) 2014; 39 Nainar, Alamelu, Arun, dan Rajasekaran (bib17) 2016; 1 Lemos, Gurgel, dan Freitas (bib18) 2015; 14 Saleh, Kurniati, dan Syarif (bib14) 2016; 16 Beltrán-Aguilar, Eke, Thornton-Evans, Petersen (bib8) 2012; 60 Salama, Matthew, Masashi (bib5) 2014; 28 Etchegaray-Morales, Méndez-Martínez, Jiménez-Hernández, Mendoza-Pinto, Alonso-García, Montiel-Jarquín (bib9) 2017; 12 Hiraki, Benseler, Tyrrell (bib15) 2008; 152 Pandruvada, Gonzalez, Kirakodu, Gudhimella, Stromberg, Ebersole, Orraca, Gonzalez-Martinez, Novak, Huja (bib13) 2016; 43 Mukaka (bib11) 2012; 24 Diah, Nugreheni (bib3) 2018; 2 Gan, Patel (bib10) 2013; 133 Lang, Bartold (bib2) 2018; 45 Rutter-Locher (10.1016/j.jtumed.2019.09.005_bib4) 2017; 6 Pandruvada (10.1016/j.jtumed.2019.09.005_bib13) 2016; 43 Mukaka (10.1016/j.jtumed.2019.09.005_bib11) 2012; 24 Nazir (10.1016/j.jtumed.2019.09.005_bib1) 2017; 1 Hajishengallis (10.1016/j.jtumed.2019.09.005_bib6) 2010; 25 Etchegaray-Morales (10.1016/j.jtumed.2019.09.005_bib9) 2017; 12 Isaza-Guzmán (10.1016/j.jtumed.2019.09.005_bib19) 2015; 60 Lemos (10.1016/j.jtumed.2019.09.005_bib18) 2015; 14 Gan (10.1016/j.jtumed.2019.09.005_bib10) 2013; 133 Fulop (10.1016/j.jtumed.2019.09.005_bib7) 2014; 39 Mizraji (10.1016/j.jtumed.2019.09.005_bib20) 2017; 18 Saleh (10.1016/j.jtumed.2019.09.005_bib14) 2016; 16 Beltrán-Aguilar (10.1016/j.jtumed.2019.09.005_bib8) 2012; 60 Hajishengallis (10.1016/j.jtumed.2019.09.005_bib12) 2014; 56 Hiraki (10.1016/j.jtumed.2019.09.005_bib15) 2008; 152 Lang (10.1016/j.jtumed.2019.09.005_bib2) 2018; 45 Isenberg (10.1016/j.jtumed.2019.09.005_bib16) 2007; 46 Salama (10.1016/j.jtumed.2019.09.005_bib5) 2014; 28 Diah (10.1016/j.jtumed.2019.09.005_bib3) 2018; 2 Nainar (10.1016/j.jtumed.2019.09.005_bib17) 2016; 1 |
References_xml | – volume: 152 start-page: 550 year: 2008 end-page: 556 ident: bib15 article-title: Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study publication-title: J Pediatr – volume: 56 start-page: 30 year: 2014 end-page: 37 ident: bib12 article-title: Aging and its impact on innate immunity and inflammation: implications for periodontitis publication-title: J Oral Biosci – volume: 14 start-page: 106 year: 2015 end-page: 111 ident: bib18 article-title: Th2 cells and the IFN-γ R1 subunit in early and advanced experimental periodontitis in rats; an immunohistochemical study publication-title: Braz J Oral Sci – volume: 1 start-page: 70 year: 2016 end-page: 75 ident: bib17 article-title: Immunological profile of periapical and periodontal lesions: current concept in the role of T cells publication-title: J Oper Dent Endod – volume: 45 start-page: S9 year: 2018 end-page: S16 ident: bib2 article-title: Periodontal health publication-title: J Clin Periodontol – volume: 2 start-page: 108 year: 2018 end-page: 115 ident: bib3 article-title: Difference gingivitis total incidence between pre-puberty and puberty age in Malang publication-title: E-Prodenta Journal of Dentistry – volume: 16 start-page: 292 year: 2016 end-page: 298 ident: bib14 article-title: Assesment of systemic lupus erytematous using SLEDAI score in pediatric department RSCM jakarta Indonesia publication-title: Sari Pediatri – volume: 60 start-page: 91 year: 2015 end-page: 99 ident: bib19 article-title: Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis publication-title: Arch Oral Biol – volume: 1 start-page: 72 year: 2017 end-page: 80 ident: bib1 article-title: Prevalence of periodontal disease, its association with systemic diseases and prevention publication-title: Int J Health Sci – volume: 28 start-page: 99 year: 2014 end-page: 114 ident: bib5 article-title: Cellular senescence and its effector programs publication-title: Genes Dev – volume: 39 start-page: 163 year: 2014 end-page: 176 ident: bib7 article-title: On the immunological theory of aging publication-title: Aging: Facts and Theories – volume: 46 start-page: 1052 year: 2007 end-page: 1056 ident: bib16 article-title: Fifty years of anti-dsDNA antibodies: are we approaching journey's end? publication-title: Rheumatology – volume: 60 start-page: 40 year: 2012 end-page: 53 ident: bib8 article-title: Recording and surveillance systems for periodontal diseases publication-title: Periodontology 2000 – volume: 25 start-page: 25 year: 2010 end-page: 37 ident: bib6 article-title: Too old to fight? Aging and its toll on innate immunity publication-title: Molecular Oral Microbiology – volume: 18 start-page: 419 year: 2017 end-page: 431 ident: bib20 article-title: Cell reports porphyromonas gingivalis promotes unrestrained type I interferon production by dysregulating TAM signaling via MYD88 degradation publication-title: Cell Rep – volume: 12 year: 2017 ident: bib9 article-title: Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol publication-title: PLoS One – volume: 6 start-page: 127 year: 2017 end-page: 129 ident: bib4 article-title: Periodontal disease and autoimmunity: what we have learned from microbiome in rheumatology publication-title: J intech – volume: 43 start-page: 408 year: 2016 end-page: 417 ident: bib13 article-title: Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates publication-title: J Clin Periodontol – volume: 133 start-page: 54 year: 2013 end-page: 59 ident: bib10 article-title: Enzyme immunoassay and enzyme-linked immunosorbent assay publication-title: J Investig Dermatol – volume: 24 start-page: 69 year: 2012 end-page: 71 ident: bib11 article-title: A guide to appropriate use of Correlation coefficient in medical research publication-title: Malawi Med J: The Journal of Medical Association of Malawi – volume: 6 start-page: 127 year: 2017 ident: 10.1016/j.jtumed.2019.09.005_bib4 article-title: Periodontal disease and autoimmunity: what we have learned from microbiome in rheumatology publication-title: J intech – volume: 28 start-page: 99 year: 2014 ident: 10.1016/j.jtumed.2019.09.005_bib5 article-title: Cellular senescence and its effector programs publication-title: Genes Dev doi: 10.1101/gad.235184.113 – volume: 24 start-page: 69 issue: 3 year: 2012 ident: 10.1016/j.jtumed.2019.09.005_bib11 article-title: A guide to appropriate use of Correlation coefficient in medical research publication-title: Malawi Med J: The Journal of Medical Association of Malawi – volume: 56 start-page: 30 issue: 1 year: 2014 ident: 10.1016/j.jtumed.2019.09.005_bib12 article-title: Aging and its impact on innate immunity and inflammation: implications for periodontitis publication-title: J Oral Biosci – volume: 152 start-page: 550 issue: 4 year: 2008 ident: 10.1016/j.jtumed.2019.09.005_bib15 article-title: Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study publication-title: J Pediatr doi: 10.1016/j.jpeds.2007.09.019 – volume: 25 start-page: 25 year: 2010 ident: 10.1016/j.jtumed.2019.09.005_bib6 article-title: Too old to fight? Aging and its toll on innate immunity publication-title: Molecular Oral Microbiology doi: 10.1111/j.2041-1014.2009.00562.x – volume: 60 start-page: 91 issue: 1 year: 2015 ident: 10.1016/j.jtumed.2019.09.005_bib19 article-title: Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis publication-title: Arch Oral Biol doi: 10.1016/j.archoralbio.2014.09.002 – volume: 39 start-page: 163 year: 2014 ident: 10.1016/j.jtumed.2019.09.005_bib7 article-title: On the immunological theory of aging publication-title: Aging: Facts and Theories doi: 10.1159/000358904 – volume: 14 start-page: 106 issue: 2 year: 2015 ident: 10.1016/j.jtumed.2019.09.005_bib18 article-title: Th2 cells and the IFN-γ R1 subunit in early and advanced experimental periodontitis in rats; an immunohistochemical study publication-title: Braz J Oral Sci doi: 10.1590/1677-3225v14n2a02 – volume: 1 start-page: 72 issue: 2 year: 2017 ident: 10.1016/j.jtumed.2019.09.005_bib1 article-title: Prevalence of periodontal disease, its association with systemic diseases and prevention publication-title: Int J Health Sci – volume: 43 start-page: 408 year: 2016 ident: 10.1016/j.jtumed.2019.09.005_bib13 article-title: Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates publication-title: J Clin Periodontol doi: 10.1111/jcpe.12528 – volume: 1 start-page: 70 issue: 2 year: 2016 ident: 10.1016/j.jtumed.2019.09.005_bib17 article-title: Immunological profile of periapical and periodontal lesions: current concept in the role of T cells publication-title: J Oper Dent Endod – volume: 18 start-page: 419 year: 2017 ident: 10.1016/j.jtumed.2019.09.005_bib20 article-title: Cell reports porphyromonas gingivalis promotes unrestrained type I interferon production by dysregulating TAM signaling via MYD88 degradation publication-title: Cell Rep doi: 10.1016/j.celrep.2016.12.047 – volume: 46 start-page: 1052 issue: 7 year: 2007 ident: 10.1016/j.jtumed.2019.09.005_bib16 article-title: Fifty years of anti-dsDNA antibodies: are we approaching journey's end? publication-title: Rheumatology doi: 10.1093/rheumatology/kem112 – volume: 45 start-page: S9 year: 2018 ident: 10.1016/j.jtumed.2019.09.005_bib2 article-title: Periodontal health publication-title: J Clin Periodontol doi: 10.1111/jcpe.12936 – volume: 16 start-page: 292 issue: 4 year: 2016 ident: 10.1016/j.jtumed.2019.09.005_bib14 article-title: Assesment of systemic lupus erytematous using SLEDAI score in pediatric department RSCM jakarta Indonesia publication-title: Sari Pediatri doi: 10.14238/sp16.4.2014.292-8 – volume: 2 start-page: 108 issue: 1 year: 2018 ident: 10.1016/j.jtumed.2019.09.005_bib3 article-title: Difference gingivitis total incidence between pre-puberty and puberty age in Malang publication-title: E-Prodenta Journal of Dentistry doi: 10.21776/ub.eprodenta.2018.002.01.2 – volume: 133 start-page: 54 issue: 12 year: 2013 ident: 10.1016/j.jtumed.2019.09.005_bib10 article-title: Enzyme immunoassay and enzyme-linked immunosorbent assay publication-title: J Investig Dermatol – volume: 12 issue: 1 year: 2017 ident: 10.1016/j.jtumed.2019.09.005_bib9 article-title: Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol publication-title: PLoS One doi: 10.1371/journal.pone.0170209 – volume: 60 start-page: 40 issue: 1 year: 2012 ident: 10.1016/j.jtumed.2019.09.005_bib8 article-title: Recording and surveillance systems for periodontal diseases publication-title: Periodontology 2000 doi: 10.1111/j.1600-0757.2012.00446.x |
SSID | ssj0001105222 |
Score | 2.170101 |
Snippet | لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية... To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ)... الملخص: أهداف البحث: لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 560 |
SubjectTerms | Anti-dsDNA antibody ELISA IFN-γ Original Periodontitis SLE الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة التهاب اللثة الذئبة الحمامية المجموعية المضاد الضوئي المناعي مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا) |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxJvykpG4WuThOPFxeaxWSKw4sNLerLFjQ1fdZNUkB34O_5QZO6laOPSClF5qp44748w3nvE3jL0LCiDUCnAh6ULI3LZCQ9BCWldYcKEqXcy2uFDnl_LLVXW1V-qLcsISPXD6496XlfQKdOFAoueCGoh4OctdBrVXFtEHvX3R5u05U3F3BWFDCiHkaGJFiXZ8OTcXk7uuR1z5RBSa60hzStXr9uxSpO8_ME__ws-_syj3zNLZA3Z_xpP8NM3jIbvju0fs7tc5Yv6Y_f6GKoauZ6ROHTheMAvEt5w2YfkcouH4DJ4q2XHoWvyMa9H2k91gA45L--T808VpbLB9m3oR18Q2-G3fiR9wcwN8QylIOErHZ77WIY2R-KLXjm-m22ngfvsrkcX2wzQ8YZdnn79_PBdzWQbhqkKPommCUnWde1853RRQSg1Z1dYoWWLaQcCSh8a2oCjwkjsUmALs75W26Mw5XT5lJ13f-ed0YLxotbdgQ91IW_km-LqBrAkyOJ21fsXKRSjGzZzlVDpjY5bktGuTRGlIlCbDK6tWTOzuuk2cHUf6fyB57_oS43b8AvXQzHpojunhitWLtpgZvCRQgj-1PjL820W5DK5tCthA5_tpMEVZ0kljXeYr9iwp2-4h8dWJ3qjEu-sDNTyYxWFLt_4Z-cOVlgQ0X_yPab9k92gqKcHnFTsZt5N_jTBttG_iivwDCto9hA priority: 102 providerName: Directory of Open Access Journals |
Title | Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus |
URI | https://dx.doi.org/10.1016/j.jtumed.2019.09.005 https://www.ncbi.nlm.nih.gov/pubmed/31908645 https://www.proquest.com/docview/2334269931 https://pubmed.ncbi.nlm.nih.gov/PMC6940663 https://doaj.org/article/354e6a92ca444631842801c0a7e6b193 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh9JL6bvbR1ChV7F-yA8dk7QhFBoKbWBvRpKl1GFjL34c-nPyTzMjydu4PQQK3sNa0kraGY1mNDOfCPlkcyltkUtYSCJhPFY1E9IKxpVOlNQ2S7WLtrjIzy_51022OSCncy4MhlUG2e9lupPW4c06_JvrXdOsf8SweaYIgCWASWGxgBxOeemS-DYnf85ZQIHwzgSsz7DBnEHnwryuR5ABCBkaCwd4ivfY3duhHJD_YqP6VxH9O57y3gZ19pQ8CZolPfaDf0YOTPucPPoWfOcvyO13YDYwQh2I6kDhkYE0pqZ4HEuDs4bCGAzeaUdlW8NnbFjdTWoLBdAvnpjTzxfHrkB1ta-FqBO9NX3Xsit5cyPpFoORoJeWBuTWwffhkaMbTbfTbhqo6X972NhumIaX5PLsy8_TcxYuaGA6S8TIytLmeVHExmRalIlMuZBRVhdAY8TcAdUltqWqZY4umFiXoA1IqG9yocCs0yJ9RQ7brjVvMHU8qYVRUtmi5CozpTVFKaPScqtFVJsVSWeiVDqgl-MlGttqDlO7rjwpKyRlFcETZSvC9q12Hr3jgfonSO99XcTedi-6_qoKzFelGTe5FImWHGxpkIlgwcFsIgkTU8CMK1LM3FItWBl-qnmg-48zc1WwytF1I1vTTUOVpCnmHIs0XpHXntn2gwQhCnYph9bFgg0Xs1iWtM0vhySeC44q59v_HvE78hi_-fie9-Rw7CfzAbS0UR25040jtxjvAAqSQUQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s3yNBLXaPN04mNbqLbQrpBopb1ZtmOXVNtklceBn8M_ZSZ2li4cKiFlL7G9tjOfxzP2-DMhHy2T0uZMwkDicZBGqgy4tDxIlY6V1DZL9BhtsWSLi_TLKlvtkaPpLAyGVXrd73T6qK39m7n_mvNNVc2_RzB5JkiAxQGkMFjukLtgDTCE9snq8M9CC1gQbjcBCwRYYjpCN8Z5XfWgBJAzNOIj4yleZHdjihqZ_Hdmqn8t0b8DKm_MUMePyENvWtID1_rHZM_UT8i9M795_pT8-gZoAy90ZFHtKDzSy8aUFNdjqd-todAGg5faUVmX8OuroGwGtYYEqBeXzOmn5cGYoJrS5ULaidaatqmDS3l9Lekao5Gglpp66tbO1eGooytN18Nm6Khpfzre2KYbumfk4vjz-dEi8Dc0BDqLeR8UhWUszyNjMs2LWCYpl2FW5iBkJN0B2yWyhSolwz2YSBdgDkjIbxhX4Ndpnjwn-3VTm5d4djwuuVFS2bxIVWYKa_JChoVNreZhaWYkmYQitKcvx1s01mKKU7sSTpQCRSlCeMJsRoJtqY2j77gl_yHKe5sXybfHF017KTz6RJKlhkkea5mCMw1KEVw46E0ooWMK0Dgj-YQWsYNl-Kvqluo_TOASMMxx70bWphk6EScJHjrmSTQjLxzYto0ELQqOaQql8x0Y7vRiN6WufoxU4oynaHO--u8Wvyf3F-dnp-L0ZPn1NXmAKS7Y5w3Z79vBvAWTrVfvxiH5G6txQ3Y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Periodontitis+is+associated+with+disease+severity+and+anti-double+stranded+DNA+antibody+and+interferon-gamma+levels+in+patients+with+systemic+lupus+erythematosus&rft.jtitle=Journal+of+Taibah+University+Medical+Sciences&rft.au=Gofur%2C+Nanda+R+P&rft.au=Nurdiana%2C+Nurdiana&rft.au=Kalim%2C+Handono&rft.au=Handono%2C+Kusworini&rft.date=2019-12-01&rft.eissn=1658-3612&rft.volume=14&rft.issue=6&rft.spage=560&rft_id=info:doi/10.1016%2Fj.jtumed.2019.09.005&rft_id=info%3Apmid%2F31908645&rft.externalDocID=31908645 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1658-3612&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1658-3612&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1658-3612&client=summon |